Increased Expression of Inducible Cyclooxygenase-2 in Human Endothelial Cells by Antiphospholipid Antibodies
暂无分享,去创建一个
[1] J. Maclouf,et al. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. , 1993, The Journal of biological chemistry.
[2] J. Maclouf,et al. Antiphospholipid Antibodies Enhance Thrombin-Induced Platelet Activation and Thromboxane Formation , 1993, Thrombosis and Haemostasis.
[3] W. Dean,et al. Are immunoglobulins with lupus anticoagulant activity specific for phospholipids? , 1993, British journal of haematology.
[4] J. Maclouf,et al. The lupus anticoagulant and eicosanoids. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.
[5] David A Jones,et al. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.
[6] S. Hart,et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. , 1992, The Journal of biological chemistry.
[7] T. Hla,et al. Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. Smith. Prostanoid biosynthesis and mechanisms of action. , 1992, The American journal of physiology.
[9] M. Gerritsen,et al. Fibroblast growth factor upregulates PGG/H synthase in rabbit microvascular endothelia cells by a glucocorticoid independent mechanism , 1992, Journal of cellular physiology.
[10] T. Barbui,et al. Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin , 1991, Thrombosis and Haemostasis.
[11] J. Maclouf,et al. Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. , 1991, Blood.
[12] S. Machin,et al. Guidelines for Testing and Revised Criteria for Lupus Anticoagulants , 1991, Thrombosis and Haemostasis.
[13] H. Johnsson,et al. Increased thromboxane formation in patients with antiphospholipid syndrome , 1990, European journal of clinical investigation.
[14] T. Barbui,et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.
[15] C. Chesterman,et al. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[16] L. Carreras,et al. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant. , 1990, Haemostasis.
[17] A. Schorer,et al. Lupus anticoagulant induces a selective defect in thrombin‐mediated endothelial prostacyclin release and platelet aggregation , 1989, British journal of haematology.
[18] J. Soria,et al. Effect of Lupus Anticoagulant on Antithrombogenic Properties of Endothelial Cells - Inhibition of Thrombomodulin-Dependent Protein C Activation , 1988, Thrombosis and Haemostasis.
[19] T. S. Walker,et al. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. , 1988, Thrombosis research.
[20] R. Derksen,et al. Thrombosis Associated with Antiphospholipid Antibodies Cannot Be Explained by Effects on Endothelial and Platelet Prostanoid Synthesis , 1988, Thrombosis and Haemostasis.
[21] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[22] L Roy,et al. Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.
[23] J. Maclouf,et al. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. , 1985, Analytical chemistry.
[24] A. K. Pedersen,et al. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. , 1984, The New England journal of medicine.
[25] A. Eldor,et al. Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. , 1984, Archives of internal medicine.
[26] A. Feinberg,et al. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. , 1984, Analytical biochemistry.
[27] J. Fontcuberta,et al. LUPUS ANTICOAGULANT, RECURRENT ABORTION, AND PROSTACYCLIN PRODUCTION BY CULTURED SMOOTH MUSCLE CELLS , 1983, The Lancet.
[28] G. FitzGerald,et al. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.
[29] J. Vermylen,et al. “Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation , 1982, Thrombosis and Haemostasis.
[30] J. Vermylen,et al. “LUPUS” ANTICOAGULANT AND INHIBITION OF PROSTACYCLIN FORMATION IN PATIENTS WITH REPEATED ABORTION, INTRAUTERINE GROWTH RETARDATION AND INTRAUTERINE DEATH , 1981, British journal of obstetrics and gynaecology.
[31] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.
[32] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.